Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.
作者信息
Casscells W, Willerson J T
出版信息
J Clin Invest. 1995 Jun;95(6):2425-6. doi: 10.1172/JCI117938.
Abstract
摘要
相似文献
1
Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.嗜异性而非嗜动脉性：腺病毒基因治疗的另一个注意事项。
J Clin Invest. 1995 Jun;95(6):2425-6. doi: 10.1172/JCI117938.
2
Current advances and future challenges in Adenoviral vector biology and targeting.腺病毒载体生物学与靶向性的当前进展及未来挑战
Curr Gene Ther. 2007 Jun;7(3):189-204. doi: 10.2174/156652307780859062.
3
Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases.
Acta Orthop Scand. 1999 Oct;70(5):419-24. doi: 10.3109/17453679909000974.
4
The evolution of adenoviral vectors through genetic and chemical surface modifications.腺病毒载体通过遗传和化学表面修饰的演变。
Viruses. 2014 Feb 17;6(2):832-55. doi: 10.3390/v6020832.
5
Emerging adenoviral vectors for stable correction of genetic disorders.用于稳定纠正遗传疾病的新型腺病毒载体。
Curr Gene Ther. 2007 Aug;7(4):272-83. doi: 10.2174/156652307781369074.
6
Genetic strategy to decrease complement activation with adenoviral therapies.利用腺病毒疗法降低补体激活的遗传策略。
PLoS One. 2019 Apr 26;14(4):e0215226. doi: 10.1371/journal.pone.0215226. eCollection 2019.
7
Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.基于人19a型腺病毒的腺病毒载体在人类肌肉定向基因治疗方面具有很高的潜力。
Hum Gene Ther. 2006 Feb;17(2):193-205. doi: 10.1089/hum.2006.17.193.
8
Adenovirus vectors for human gene therapy.用于人类基因治疗的腺病毒载体。
Adv Virus Res. 2000;55:479-505. doi: 10.1016/s0065-3527(00)55014-3.
9
Gene therapy: adenovirus vectors.基因治疗：腺病毒载体
Curr Opin Genet Dev. 1993 Jun;3(3):499-503. doi: 10.1016/0959-437x(93)90126-a.
10
Adenovirus mediated gene transfer of vascular smooth muscle cells and endothelial cells in vitro.腺病毒介导的血管平滑肌细胞和内皮细胞的体外基因转移。
Chin Med J (Engl). 1995 Jul;108(7):493-6.
引用本文的文献
1
Autoimmunity, immunologic tolerance, and gene therapy.
Immunol Res. 1998;17(1-2):33-40. doi: 10.1007/BF02786428.
2
Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.通过CD95（Apo-1/Fas）配体基因转移改善胶原诱导的关节炎。
J Clin Invest. 1997 Oct 15;100(8):1951-7. doi: 10.1172/JCI119726.
本文引用的文献
1
The pathogenesis of atherosclerosis: a perspective for the 1990s.动脉粥样硬化的发病机制：20世纪90年代的展望
Nature. 1993 Apr 29;362(6423):801-9. doi: 10.1038/362801a0.
2
Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies.碱性成纤维细胞生长因子在牛内皮细胞中的定位：免疫组织化学和生物化学研究。
Exp Cell Res. 1993 Feb;204(2):247-59. doi: 10.1006/excr.1993.1031.
3
Defective parvoviruses may be good for your health!有缺陷的细小病毒可能对你的健康有益！
Prog Med Virol. 1993;40:193-205.
4
The advent of adenovirus. Gene therapy for cardiovascular disease.腺病毒的出现。心血管疾病的基因治疗。
Circulation. 1993 Oct;88(4 Pt 1):1937-42. doi: 10.1161/01.cir.88.4.1937.
5
Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation.钠氢交换抑制剂可减少大鼠颈动脉损伤后的新生内膜形成。对平滑肌细胞迁移和增殖的影响。
Circ Res. 1993 Aug;73(2):269-75. doi: 10.1161/01.res.73.2.269.
6
A novel gene delivery system using EGF receptor-mediated endocytosis.
FEBS Lett. 1994 Jan 31;338(2):167-9. doi: 10.1016/0014-5793(94)80357-9.
7
Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector.解剖学屏障影响体内基因转移至动脉壁的分布。采用微观示踪颗粒进行建模，并使用重组腺病毒载体进行验证。
Arterioscler Thromb. 1994 Jan;14(1):148-61. doi: 10.1161/01.atv.14.1.148.
8
Smooth muscle cell expression of extracellular matrix genes after arterial injury.动脉损伤后细胞外基质基因在平滑肌细胞中的表达
Am J Pathol. 1994 Jun;144(6):1348-56.
9
Gene therapy for vascular diseases.血管疾病的基因治疗。
Tex Heart Inst J. 1994;21(1):98-103.
10
Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells.
Circ Res. 1994 Mar;74(3):485-94. doi: 10.1161/01.res.74.3.485.
Zotero 插件